Clinical Trials

AFT-19

A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer.

Objective

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.

NCT#03009981

Clinical Trial Categories

  • Prostate Cancer
Contact
NH Oncology Hematology Clinical Research Dept. at (603) 224-2556

Location

  • Payson Center for Cancer Care
    Concord Hospital
    250 Pleasant Street
    Concord, NH 03301
    Main: (603) 230-6000